Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kathryn Horwitz to Progestins

This is a "connection" page, showing publications Kathryn Horwitz has written about Progestins.

 
Connection Strength
 
 
 
2.799
 
  1. Ogba N, Manning NG, Bliesner BS, Ambler SK, Haughian JM, Pinto MP, Jedlicka P, Joensuu K, Heikkil? P, Horwitz KB. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells. Breast Cancer Res. 2014 Dec 05; 16(6):489.
    View in: PubMed
    Score: 0.454
  2. Jacobsen BM, Horwitz KB. Progesterone receptors, their isoforms and progesterone regulated transcription. Mol Cell Endocrinol. 2012 Jun 24; 357(1-2):18-29.
    View in: PubMed
    Score: 0.363
  3. Horwitz KB. The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk. Mol Endocrinol. 2008 Dec; 22(12):2743-50.
    View in: PubMed
    Score: 0.296
  4. Horwitz KB, Sartorius CA. Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis. J Clin Endocrinol Metab. 2008 Sep; 93(9):3295-8.
    View in: PubMed
    Score: 0.292
  5. Horwitz KB, Sartorius CA. Response to: Progesterone and breast cancer pathogenesis. J Mol Endocrinol. 2021 01; 66(1):L1-L2.
    View in: PubMed
    Score: 0.173
  6. Horwitz KB, Sartorius CA. 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future. J Mol Endocrinol. 2020 07; 65(1):T49-T63.
    View in: PubMed
    Score: 0.167
  7. Horwitz K, Clarke C. Estrogens and progestins in mammary development and neoplasia. Introduction. J Mammary Gland Biol Neoplasia. 1998 Jan; 3(1):1-2.
    View in: PubMed
    Score: 0.140
  8. Horwitz KB, Tung L, Takimoto GS. Novel mechanisms of antiprogestin action. Acta Oncol. 1996; 35(2):129-40.
    View in: PubMed
    Score: 0.122
  9. Horwitz KB, Tung L, Takimoto GS. Novel mechanisms of antiprogestin action. J Steroid Biochem Mol Biol. 1995 Jun; 53(1-6):9-17.
    View in: PubMed
    Score: 0.117
  10. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res. 1994 Jul 15; 54(14):3868-77.
    View in: PubMed
    Score: 0.110
  11. Horwitz KB. Mechanisms of hormone resistance in breast cancer. Breast Cancer Res Treat. 1993; 26(2):119-30.
    View in: PubMed
    Score: 0.099
  12. Horwitz KB. The central role of progesterone receptors and progestational agents in the management and treatment of breast cancer. Semin Oncol. 1988 Apr; 15(2 Suppl 1):14-9.
    View in: PubMed
    Score: 0.071
  13. Horwitz KB. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells. Endocrinology. 1985 Jun; 116(6):2236-45.
    View in: PubMed
    Score: 0.059
  14. Horwitz KB, Wei LL, Sedlacek SM, d'Arville CN. Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog Horm Res. 1985; 41:249-316.
    View in: PubMed
    Score: 0.057
  15. Sedlacek SM, Horwitz KB. The role of progestins and progesterone receptors in the treatment of breast cancer. Steroids. 1984 Dec; 44(6):467-84.
    View in: PubMed
    Score: 0.057
  16. Wu J, Richer J, Horwitz KB, Hyder SM. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. Cancer Res. 2004 Mar 15; 64(6):2238-44.
    View in: PubMed
    Score: 0.054
  17. Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS, Horwitz KB. Progesterone receptor variants found in breast cells repress transcription by wild-type receptors. Breast Cancer Res Treat. 1998 Apr; 48(3):231-41.
    View in: PubMed
    Score: 0.036
  18. Horwitz KB. How do breast cancers become hormone resistant? J Steroid Biochem Mol Biol. 1994 Jun; 49(4-6):295-302.
    View in: PubMed
    Score: 0.027
  19. Horwitz KB. Hormone 'resistance' in breast cancer: the role of normal and mutant steroid receptors. Cancer Treat Res. 1994; 71:111-27.
    View in: PubMed
    Score: 0.027
  20. Horwitz KB. Hormone-resistant breast cancer or "feeding the hand that bites you". Prog Clin Biol Res. 1994; 387:29-45.
    View in: PubMed
    Score: 0.027
  21. Sheridan PL, Evans RM, Horwitz KB. Phosphotryptic peptide analysis of human progesterone receptor. New phosphorylated sites formed in nuclei after hormone treatment. J Biol Chem. 1989 Apr 15; 264(11):6520-8.
    View in: PubMed
    Score: 0.019
  22. Horwitz KB. The structure and function of progesterone receptors in breast cancer. J Steroid Biochem. 1987; 27(1-3):447-57.
    View in: PubMed
    Score: 0.016
  23. Bray JD, Jelinsky S, Ghatge R, Bray JA, Tunkey C, Saraf K, Jacobsen BM, Richer JK, Brown EL, Winneker RC, Horwitz KB, Lyttle CR. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. J Steroid Biochem Mol Biol. 2005 Dec; 97(4):328-41.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)